Bio-path holdings inc (BPTH)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

13

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Operating expenses
Research and development

2,008

1,289

1,375

1,523

398

502

2,342

827

932

1,391

1,583

1,480

1,026

954

2,313

1,187

1,020

871

992

564

593

580

424

517

107

-

-

156

401

-

-

-

-

-

-

-

-

-

-

General and administrative

1,336

1,124

896

966

1,122

800

740

852

987

815

893

845

970

727

681

757

849

592

520

567

786

866

713

754

380

344

810

240

239

256

246

252

231

222

327

324

350

265

296

Total operating expenses

3,344

2,413

2,271

2,489

1,520

1,910

3,082

1,679

1,919

2,206

2,476

2,325

1,996

1,681

2,994

1,944

1,869

1,463

1,512

1,131

1,379

1,602

1,154

1,274

510

790

1,393

428

655

431

840

787

522

804

504

463

592

501

426

Net operating loss

-3,344

-2,413

-2,271

-2,489

-1,520

-1,910

-3,082

-1,679

-1,919

-2,169

-2,476

-2,325

-1,996

-1,668

-2,994

-1,944

-1,869

-1,463

-1,512

-1,131

-1,379

-1,602

-1,154

-1,274

-510

-790

-1,393

-428

-655

-431

-840

-787

-522

-804

-504

-463

-592

-501

-426

Other income (loss)
Change in fair value of warrant liability

-

-

-

-

-

-

-

-

-

0

0

-778

-1,596

-293

-1,420

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on extinguishment of warrant liability

-

-

-

-

-

-

-

-

-

-

0

-440

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

20

24

29

33

8

1

1

2

3

2

2

2

3

4

4

2

2

5

4

5

4

5

5

6

5

1

0

1

0

0

0

0

0

0

0

1

0

0

0

Other income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

0

-

-

-

-

Other expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Total other income

20

24

29

33

8

1

1

2

3

2

2

340

1,599

297

1,424

2

2

5

4

5

4

5

5

6

5

1

0

1

-0

-0

-0

-0

0

0

0

1

0

-0

0

Net loss before income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-592

-

-

Net loss

-3,324

-2,389

-2,242

-2,456

-1,512

-1,909

-3,081

-1,677

-1,916

-2,167

-2,474

-1,985

-397

-1,371

-1,570

-1,942

-1,867

-1,458

-1,508

-1,126

-1,375

-1,596

-1,148

-1,268

-504

-789

-1,393

-427

-656

-431

-840

-787

-522

-

-503

-462

-

-501

-426

Deemed dividend related to warrant conversion

-

-

-

-

-

-

-

-

-

-

0

-1,038

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss attributable to common stockholders

-

-

-

-

-

-

-

-

-

-

-2,474

3,023

-

-

-1,570

-1,942

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss per share, basic and diluted (in dollars)

-0.90

-0.70

-0.78

-0.87

-0.89

-2.66

-5.38

-2.96

-3.38

-15.39

-0.25

-0.31

-0.04

-0.67

-0.02

-0.02

-0.02

-0.01

-0.02

-0.01

-0.02

-0.02

-0.01

-0.01

-0.01

-0.01

-0.02

-0.01

-0.01

-0.01

-0.01

-0.01

-0.01

-0.01

-0.01

-0.01

-0.01

-0.01

-0.01

Basic and diluted weighted average number of common shares outstanding

3,692

3,228

2,872

2,828

1,700

681

573

567

567

-27,414

10,006

9,859

9,565

-238,091

95,645

89,763

89,763

358,782

89

89

89

89,414

89,237

89,237

89,237

81,285

75,380

66,606

62,219

61,118

58,902

58,868

58,381

-

56,146

51,649

-

-

-

Basic and diluted weighted average number of common shares outstanding

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

49,400

49,083

47,565